Have your own idea? Try our Stock Screener
Chinese (SSE) Biotech Industry Analysis
UpdatedAug 22, 2026
DataAggregated Company Financials
Companies75
- 7D-0.7%
- 3M0.4%
- 1Y-23.1%
- YTD-12.1%
Over the last 7 days, the Biotech industry has remained flat, although notably Walvax Biotechnology gained 21%. As for the longer term, the industry has declined 23% in the last year. Looking forward, earnings are forecast to grow by 30% annually.
Industry Valuation and Performance
Has the Chinese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 23 Aug 2026 | CN¥844.8b | CN¥110.3b | -CN¥8,424,876,126.00 | 53.9x | -100.3x | 7.7x |
| Tue, 21 Jul 2026 | CN¥806.0b | CN¥109.9b | -CN¥8,630,064,105.00 | 51.4x | -93.4x | 7.3x |
| Thu, 18 Jun 2026 | CN¥731.9b | CN¥109.9b | -CN¥8,632,180,561.00 | 46.2x | -84.8x | 6.7x |
| Sat, 16 May 2026 | CN¥874.7b | CN¥110.0b | -CN¥8,670,585,873.00 | 52x | -100.9x | 8x |
| Mon, 13 Apr 2026 | CN¥914.2b | CN¥109.9b | CN¥4.7b | 45.3x | 193.4x | 8.3x |
| Wed, 11 Mar 2026 | CN¥917.9b | CN¥109.6b | CN¥5.5b | 45.7x | 166.5x | 8.4x |
| Fri, 06 Feb 2026 | CN¥931.7b | CN¥106.1b | CN¥3.8b | 47.9x | 247x | 8.8x |
| Sun, 04 Jan 2026 | CN¥914.9b | CN¥106.1b | CN¥3.8b | 47.4x | 242.5x | 8.6x |
| Tue, 02 Dec 2025 | CN¥977.6b | CN¥106.1b | CN¥3.8b | 52x | 259.1x | 9.2x |
| Thu, 30 Oct 2025 | CN¥976.3b | CN¥107.7b | CN¥4.5b | 49.9x | 216.8x | 9.1x |
| Sat, 27 Sep 2025 | CN¥954.2b | CN¥107.5b | CN¥5.0b | 50.4x | 189.4x | 8.9x |
| Mon, 25 Aug 2025 | CN¥1.0t | CN¥109.3b | CN¥5.8b | 43.9x | 178.5x | 9.5x |
| Wed, 23 Jul 2025 | CN¥949.1b | CN¥112.9b | CN¥8.2b | 42.8x | 115.2x | 8.4x |
| Fri, 20 Jun 2025 | CN¥849.7b | CN¥113.0b | CN¥8.3b | 35.3x | 102.5x | 7.5x |
| Sun, 18 May 2025 | CN¥819.0b | CN¥113.3b | CN¥8.3b | 35.3x | 98.7x | 7.2x |
| Tue, 15 Apr 2025 | CN¥854.7b | CN¥135.0b | CN¥11.8b | 31.7x | 72.4x | 6.3x |
| Thu, 13 Mar 2025 | CN¥855.5b | CN¥136.2b | CN¥11.6b | 32x | 74x | 6.3x |
| Sat, 08 Feb 2025 | CN¥823.9b | CN¥136.0b | CN¥10.8b | 33.4x | 76.6x | 6.1x |
| Mon, 06 Jan 2025 | CN¥801.6b | CN¥136.0b | CN¥10.8b | 32.5x | 74.5x | 5.9x |
| Wed, 04 Dec 2024 | CN¥903.9b | CN¥136.0b | CN¥10.8b | 34.6x | 84x | 6.6x |
| Fri, 01 Nov 2024 | CN¥904.8b | CN¥141.8b | CN¥11.2b | 36.9x | 80.7x | 6.4x |
| Sun, 29 Sep 2024 | CN¥853.6b | CN¥154.1b | CN¥14.5b | 36x | 59.1x | 5.5x |
| Tue, 27 Aug 2024 | CN¥766.3b | CN¥159.9b | CN¥16.8b | 27.5x | 45.7x | 4.8x |
| Thu, 25 Jul 2024 | CN¥800.4b | CN¥161.1b | CN¥17.3b | 30.3x | 46.3x | 5x |
| Sat, 22 Jun 2024 | CN¥859.3b | CN¥161.1b | CN¥17.3b | 32.2x | 49.7x | 5.3x |
| Mon, 20 May 2024 | CN¥952.3b | CN¥161.1b | CN¥17.3b | 39.1x | 55.2x | 5.9x |
| Wed, 17 Apr 2024 | CN¥926.5b | CN¥161.4b | CN¥20.3b | 35.1x | 45.6x | 5.7x |
| Fri, 15 Mar 2024 | CN¥1.0t | CN¥165.4b | CN¥21.9b | 38.3x | 47x | 6.2x |
| Sun, 11 Feb 2024 | CN¥955.7b | CN¥167.9b | CN¥21.4b | 31.9x | 44.6x | 5.7x |
| Tue, 09 Jan 2024 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 37.9x | 49.7x | 6.3x |
| Thu, 07 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39.7x | 52.6x | 6.7x |
| Sat, 04 Nov 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 40.3x | 50.6x | 6.5x |
| Mon, 02 Oct 2023 | CN¥1.1t | CN¥170.9b | CN¥25.2b | 42.6x | 41.7x | 6.2x |
| Wed, 30 Aug 2023 | CN¥1.0t | CN¥175.2b | CN¥27.8b | 37.7x | 36.2x | 5.8x |
Price to Earnings Ratio
36.2x
Current Industry PE
- Investors are relatively neutral on the Chinese Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 7.0x.
Past Earnings Growth
- Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 14% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | -1.45% | |
| Healthcare | -2.49% | |
| Biotech | -0.71% | |
| Biotech | -0.71% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 300142 Walvax Biotechnology | CN¥16.10 | 21.2% +CN¥4.5b | 22.6% | PE90.1x | |
| 688266 Suzhou Zelgen Biopharmaceuticals | CN¥128.71 | 6.9% +CN¥2.2b | 18.0% | PE62x | |
| 300122 Chongqing Zhifei Biological Products | CN¥13.90 | 6.4% +CN¥2.0b | -40.0% | PS3.8x | |
| 301080 AcrobiosystemsLtd | CN¥98.92 | 9.7% +CN¥1.5b | 71.1% | PE96.6x | |
| 002038 Beijing SL Pharmaceutical | CN¥7.08 | 17.2% +CN¥1.1b | -12.9% | PS12.3x |